Neurodegenerative diseases

Atención, se abre en una ventana nueva.
  • Imprimir
  • ARACLON BIOTECH

    The CIBIR, conscious of the need to support private initiative and of the importance that close collaboration with the latter has – in the health and biotechnological sphere – in increasing productivity and accelerating the process of obtaining results, also houses the ARACLON BIOTECH work group.

    Dr. Manuel Sarasa and his research team, working in close collaboration with the CIBIR, develop new therapies for the treatment of neurodegenerative diseases, as well as new techniques for their diagnosis, such as the predictive kit for Alzheimer’s disease.

    Link: ARACLON BIOTECH

    alt

    Group Director

    José Manuel Sarasa Barrio

    Researchers

    Ana María Lacosta López-Alda
    María Montañés Bellosta
    María Izco Gaviria
    Virginia Pérez Grijalba
    Diego Casabona Agudo